Daré Bioscience, Inc. (DARE)
0.7843
+0.04
(+4.88%)
USD |
NASDAQ |
Sep 18, 16:00
0.7713
-0.01
(-1.66%)
Pre-Market: 20:00
Daré Bioscience Total Long Term Debt (Quarterly) : 6.169M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.169M |
| March 31, 2026 | 6.585M |
| December 31, 2025 | 7.452M |
| September 30, 2025 | 7.554M |
| June 30, 2025 | 7.511M |
| March 31, 2025 | 7.838M |
| September 30, 2024 | 5.388M |
| June 30, 2024 | 5.345M |
| March 31, 2024 | 5.287M |
| December 31, 2023 | 4.849M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0233M |
| March 31, 2023 | 0.0571M |
| December 31, 2022 | 0.0903M |
| September 30, 2022 | 0.1946M |
| June 30, 2022 | 0.8239M |
| March 31, 2022 | 0.9131M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0158M |
| June 30, 2021 | 0.0735M |
| March 31, 2021 | 0.1518M |
| December 31, 2020 | 0.4091M |
| September 30, 2020 | 0.4503M |
| June 30, 2020 | 0.5426M |
| March 31, 2020 | 0.2842M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.3896M |
| September 30, 2019 | 0.091M |
| June 30, 2019 | 0.1161M |
| March 31, 2019 | 0.1393M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 12.82M |
| September 30, 2016 | 14.74M |
| June 30, 2016 | 16.67M |
| March 31, 2016 | 18.52M |
| December 31, 2015 | 20.32M |
| September 30, 2015 | 14.56M |
| June 30, 2015 | 14.49M |
| March 31, 2015 | 14.41M |
| December 31, 2014 | 3.124M |
| September 30, 2014 | 3.934M |
| June 30, 2014 | 4.725M |
| March 31, 2014 | 5.50M |
| December 31, 2013 | 6.258M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Nektar Therapeutics | 113.23M |
| Elite Pharmaceuticals, Inc. | 5.019M |
| Eton Pharmaceuticals, Inc. | 28.99M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |